These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38387866)

  • 1. Doubly adaptive biased coin design to improve Bayesian clinical trials with time-to-event endpoints.
    Cao W; Zhu H; Wang L; Zhang L; Yu J
    Stat Med; 2024 Apr; 43(9):1743-1758. PubMed ID: 38387866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statistical inference for response adaptive randomization procedures with adjusted optimal allocation proportions.
    Zhu H
    J Biopharm Stat; 2017; 27(5):732-740. PubMed ID: 27937121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bayesian adaptive biased-coin designs for clinical trials with normal responses.
    Atkinson AC; Biswas A
    Biometrics; 2005 Mar; 61(1):118-25. PubMed ID: 15737084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Bayesian Hybrid Adaptive Randomisation Design for Clinical Trials with Survival Outcomes.
    Moatti M; Chevret S; Zohar S; Rosenberger WF
    Methods Inf Med; 2016; 55(1):4-13. PubMed ID: 26404511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resist the Temptation of Response-Adaptive Randomization.
    Proschan M; Evans S
    Clin Infect Dis; 2020 Dec; 71(11):3002-3004. PubMed ID: 32222766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequentist performance of Bayesian inference with response-adaptive designs.
    Lecoutre B; Derzko G; Elqasyr K
    Stat Med; 2010 Dec; 29(30):3219-31. PubMed ID: 21170916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A practical response adaptive block randomization (RABR) design with analytic type I error protection.
    Zhan T; Cui L; Geng Z; Zhang L; Gu Y; Chan ISF
    Stat Med; 2021 Oct; 40(23):4947-4960. PubMed ID: 34111902
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bayesian adaptive randomization designs for targeted agent development.
    Lee JJ; Xuemin Gu ; Suyu Liu
    Clin Trials; 2010 Oct; 7(5):584-96. PubMed ID: 20571130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response adaptive randomization procedures in seamless phase II/III clinical trials.
    Zhu H; Piao J; Lee JJ; Hu F; Zhang L
    J Biopharm Stat; 2020; 30(1):3-17. PubMed ID: 31454295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simulation study for evaluating the performance of response-adaptive randomization.
    Du Y; Wang X; Jack Lee J
    Contemp Clin Trials; 2015 Jan; 40():15-25. PubMed ID: 25460340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An overview of methodological considerations regarding adaptive stopping, arm dropping, and randomization in clinical trials.
    Granholm A; Kaas-Hansen BS; Lange T; Schjørring OL; Andersen LW; Perner A; Jensen AKG; Møller MH
    J Clin Epidemiol; 2023 Jan; 153():45-54. PubMed ID: 36400262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response-adaptive treatment allocation for clinical studies with recurrent event and terminal event data.
    Su PF
    Stat Med; 2022 Jan; 41(2):258-275. PubMed ID: 34693543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Robustness of response-adaptive randomization.
    Ye X; Hu F; Ma W
    Biometrics; 2024 Mar; 80(2):. PubMed ID: 38819309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bayesian response adaptive randomization using longitudinal outcomes.
    Hatayama T; Morita S; Sakamaki K
    Pharm Stat; 2015; 14(5):369-76. PubMed ID: 26099995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maximizing power and minimizing treatment failures in clinical trials.
    Rosenberger WF; Huc F
    Clin Trials; 2004; 1(2):141-7. PubMed ID: 16281886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bayesian response adaptive randomization design with a composite endpoint of mortality and morbidity.
    Xu Z; Ma T; Tang L; Talisa VB; Chang CH
    Stat Med; 2024 Mar; 43(6):1256-1270. PubMed ID: 38258898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bayesian dose selection design for a binary outcome using restricted response adaptive randomization.
    Meinzer C; Martin R; Suarez JI
    Trials; 2017 Sep; 18(1):420. PubMed ID: 28886745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A hybrid Bayesian adaptive design for dose response trials.
    Chang M; Chow SC
    J Biopharm Stat; 2005; 15(4):677-91. PubMed ID: 16022172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Bayesian Design of Adaptive Clinical Trials.
    Giovagnoli A
    Int J Environ Res Public Health; 2021 Jan; 18(2):. PubMed ID: 33435249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A simulation study of outcome adaptive randomization in multi-arm clinical trials.
    Wathen JK; Thall PF
    Clin Trials; 2017 Oct; 14(5):432-440. PubMed ID: 28982263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.